Algenex and FATRO announce positive opinion by EMA/CVMP for FATROVAX RHD

Regulatory support by Klifovet

Congratulations to ALGENEX S.L and Fatro Ibérica for receiving a positive opinion by EMA/CVMP on their vaccine FATROVAX RHD for Rabbit Viral Haemorrhagic Disease. The novel CrisBio® recombinant biologics production is based on insects to act as single-use bioreactors; a new approach to produce biological substances. The Klifovet Team is proud to have been able to contribute to this with our expertise during the regulatory submission process.

Click here to read the PRESS RELEASE